PAVmed Inc. (NASDAQ:PAVM – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.67 and traded as high as $0.80. PAVmed shares last traded at $0.79, with a volume of 537,019 shares traded.
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets reduced their target price on shares of PAVmed from $21.00 to $19.00 and set a “buy” rating for the company in a report on Monday, December 9th.
Read Our Latest Analysis on PAVmed
PAVmed Price Performance
About PAVmed
PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.
Further Reading
- Five stocks we like better than PAVmed
- How to Calculate Retirement Income: MarketBeat’s Calculator
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- CD Calculator: Certificate of Deposit Calculator
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.
